AI assistant
Sending…
Xvivo Perfusion — Major Shareholding Notification 2020
Sep 26, 2020
3130_iss_2020-09-26_e3c44938-52d9-4b99-9869-4e3e2a1cd631.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Xvivo Perfusion Aktiebolag
Holder
Fjärde AP-fonden
Instrument
| Instrument | Aktier |
|---|---|
| Before the transaction | |
| Shares | 1,250,000 |
| Voting rights | 1,250,000 |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 24/09/2020 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 1,700,000 |
| Directly held voting rights | 1,700,000 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 5.92 % |
| Directly held voting rights | 5.92 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.92 % | 1,700,000 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 5.92 % | 1,700,000 |
| Group total holdings | ||
| Voting rights 1,700,000 Percentage of voting rights 5.92 |
||
| Published 26/09/2020 20:11 |
||
| Contact | ||
| Name Jannis Kitsakis |
||
| Phone 070-6038023 Email [email protected] |
||
| CLOSE |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Xvivo Perfusion
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 27
AGM Information
2026
Apr 27
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 22
Annual Report
2026
Apr 1
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Mar 19
Board/Management Information
2026
Feb 20
Regulatory Filings
2026
Feb 20